Subscribe

Processa Pharmaceuticals, Inc. (PCSA)

USD2.39 +0.10 (+4.37%)
US NASDAQ Healthcare Biotechnology
Address 7380 Coca Cola Drive 21076
Hanover, MD, US
CEO George K. Ng
IPO 2014-03-07
CIK 1533743 ISIN US74275C4033

Explore sections of this company profile

Description

Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative and non-ulcerative manifestations of necrobiosis lipoidica, a chronic and disfiguring dermatological condition. Processa's portfolio also features PCS12852, a unique selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist. This compound is currently in Phase 2A clinical trials for its potential application in managing gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia. Furthermore, the firm is advancing PCS3117, a cytosine analog, which has reached Phase 2B clinical trials for its use in pancreatic cancer and non-small cell lung cancer. Another candidate, PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase, is progressing through Phase 1B clinical trials for metastatic colorectal and breast cancers. In addition, Processa is developing PCS11T, an analog derived from the drugs SN38 and irinotecan, intended for the treatment of diverse cancer types. The company was founded in 2011 and maintains its corporate headquarters in Hanover, Maryland.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD2.39 +0.10 (+4.37%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
67.1K
Beta
0.99
Float Shares
2.04M
Free Float %
90.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-3.03% -0.78% -5.19% +17.97% -60.49% -11.11% -65.64% -99.17% -99.92% -99.78% -99.97%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (5 ratings, all time) Buy
Price Targets & DCF
Current price
2.39
Low 225.00 +9,314.2%
Consensus 225.00 +9,314.2%
Median 225.00 +9,314.2%
High 225.00 +9,314.2%
DCF (Unlevered) 3.49 +45.9%
DCF (Levered) 4.23 +76.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 1
225.00
+9,314.2%
Quality scores
Altman Z-Score
-41.02
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
  • EPS growth Biotechnology: +29.7%
    +89.3% Q1'26: +82.7% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
    -34,660.2% Q1'26: -1,567.9% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +969.7% Q1'26: +588.4% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.01) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 3.49 Current price: 2.39
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Dec 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
est: 14.91M (-100.0%)
10.01M
10.01M – 10.01M
-32.9% YoY
10.36M
10.36M – 10.36M
+3.5% YoY
53.08M
53.08M – 53.08M
+412.6% YoY
123.91M
123.91M – 123.91M
+133.5% YoY
EBITDA
-12.05M
-13.99M
— – —
— – —
— – —
— – —
EBIT
-12.05M
-13.99M
— – —
— – —
— – —
— – —
Net Income
-11.85M
est: -12.12M (+2.2%)
-13.56M
est: -13.42M (-1.1%)
-7.86M
-7.86M – -7.86M
+41.5% YoY
-6.87M
-6.87M – -6.87M
+12.5% YoY
-7.20M
-7.20M – -7.20M
-4.8% YoY
-6.22M
-6.22M – -6.22M
+13.6% YoY
SGA
4.78M
6.18M
— – —
— – —
— – —
— – —
EPS
-96.75
est: -99.00 (+2.3%)
-10.36
est: -10.25 (-1.1%)
-6.00
-6.00 – -6.00
+41.5% YoY
-5.25
-5.25 – -5.25
+12.5% YoY
-5.50
-5.50 – -5.50
-4.8% YoY
-4.75
-4.75 – -4.75
+13.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 C+ 2/5 5/5 1/5 1/5 1/5 1/5 3/5
2026-05-27 C+ 2/5 5/5 1/5 1/5 1/5 1/5 3/5
2026-05-26 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-22 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-21 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-20 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-19 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-18 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-15 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-14 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-13 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-12 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-11 C 2/5 4/5 1/5 1/5 1/5 1/5 3/5
2026-05-08 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-06 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-05 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-04 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-9.60M
OE per share TTM
-299.71
Owner's Yield
-143.03%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
15,088.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
11
Beneficial owners (>5%)
10
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 5.9% (1) 2.09M 5.90% 2.09M CO Delaware 2018-03-22
2 David Young 1.99M 14.20% 1.69M 1.99M 10.00 IN United States of America 2020-10-13
3 CorLyst, LLC 1.14M 8.40% 1.14M 1.14M 10.00 OO Maryland 2020-10-13
4 Yuhan (USA) Corporation 750.0K 7.30% 750.0K 750.0K CO Delaware 2021-06-11
5 James E. Besser 142.4K 0.90% 142.4K 142.4K IN Delaware 2021-08-10
6 Manchester Explorer, L.P. 142.4K 0.90% 142.4K 142.4K PN Delaware 2021-08-10
7 Manchester Management Company, LLC 142.4K 0.90% 142.4K 142.4K OO Delaware 2021-08-10
8 Manchester Management PR, LLC 142.4K 0.90% 142.4K 142.4K OO Delaware 2021-08-10
9 Morgan C. Frank 142.4K 0.90% 142.4K 142.4K IN Delaware 2021-08-10
10 JEB Partners, L.P. 0.00% OO Delaware 2021-08-10

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard Extended Market ETF VXF 0.00% 31.8K 0.05%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
13
Sells
0
Shares acquired
23.1K
Shares disposed
Cash buys
13.00
Cash sales
Net activity
+23,141
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-15 Young David Director / Officer P-Purchase A Common Stock 1,545 2.97 4.6K 15,345 D
2026-05-15 SKIBSTED RUSSELL Officer P-Purchase A Common Stock 1,984 2.97 5.9K 8,466 D
2026-05-15 Ng George K Director / Officer P-Purchase A Common Stock 1,843 2.97 5.5K 7,841 D
2026-05-15 Lin Patrick Officer P-Purchase A Common Stock 1,369 2.97 4.1K 7,594 D
2026-05-15 Guy Wendy Officer P-Purchase A Common Stock 1,583 2.97 4.7K 8,011 D
2026-04-30 Young David Director / Officer P-Purchase A Common Stock 1,706 2.69 4.6K 13,813 D
2026-04-30 SKIBSTED RUSSELL Officer P-Purchase A Common Stock 2,190 2.69 5.9K 6,498 D
2026-04-30 Ng George K Director / Officer P-Purchase A Common Stock 2,034 2.69 5.5K 6,013 D
2026-04-30 Lin Patrick Officer P-Purchase A Common Stock 1,511 2.69 4.1K 6,236 D
2026-04-30 Guy Wendy Officer P-Purchase A Common Stock 1,748 2.69 4.7K 6,441 D
2026-04-30 Bigora Sian Officer P-Purchase A Common Stock 1,971 2.71 5.3K 7,481 D
2026-04-15 Young David Director / Officer P-Purchase A Common Stock 1,545 2.97 4.6K 12,107 D
2026-04-15 SKIBSTED RUSSELL Officer P-Purchase A Common Stock 1,984 2.97 5.9K 4,308 D
2026-04-15 Ng George K Director / Officer P-Purchase A Common Stock 1,843 2.97 5.5K 5,492 D
2026-04-15 Lin Patrick Officer P-Purchase A Common Stock 1,369 2.97 4.1K 4,725 D
2026-04-15 Guy Wendy Officer P-Purchase A Common Stock 1,583 2.97 4.7K 4,693 D
2026-04-15 Bigora Sian Officer P-Purchase A Common Stock 1,799 2.97 5.3K 5,510 D
2026-03-31 Young David Director / Officer P-Purchase A Common Stock 1,810 2.54 4.6K 10,562 D
2026-03-31 SKIBSTED RUSSELL Officer P-Purchase A Common Stock 2,324 2.54 5.9K 2,324 D
2026-03-31 Pannu Geraldine Director P-Purchase A Common Stock 2,072 2.54 5.3K 2,188 D
2026-03-31 Ng George K Director / Officer P-Purchase A Common Stock 2,136 2.54 5.4K 2,136 D
2026-03-31 Neal James R Director P-Purchase A Common Stock 789 2.54 2.0K 818 D
2026-03-31 Lin Patrick Officer P-Purchase A Common Stock 1,603 2.54 4.1K 3,356 D
2026-03-31 Guy Wendy Officer P-Purchase A Common Stock 1,854 2.54 4.7K 3,110 D
2026-03-31 Bigora Sian Officer P-Purchase A Common Stock 2,107 2.54 5.3K 3,711 D
2026-03-31 Baluch Khoso Director P-Purchase A Common Stock 2,269 2.54 5.8K 2,325 D
2026-01-01 Young David Director / Officer M-Exempt D Restricted Stock Units 49 0.00 0 D
2026-01-01 Lin Patrick Officer M-Exempt D Common Stock 193 0.00 0 D
2026-01-01 Guy Wendy Officer M-Exempt A Common Stock 193 0.00 1,256 D
2026-01-01 Bigora Sian Officer M-Exempt D Restricted Stock Units 249 0.00 0 D
2025-10-01 Young David Director / Officer A-Award A Restricted Stock Units 111,000 0.00 111,000 D
2025-10-01 Yorke Justin W Director A-Award A Restricted Stock Units 100,000 0.00 100,000 D
2025-10-01 SKIBSTED RUSSELL Officer A-Award A Restricted Stock Units 108,000 0.00 108,000 D
2025-10-01 Pannu Geraldine Director A-Award A Restricted Stock Units 100,000 0.00 100,000 D
2025-10-01 Ng George K Director / Officer A-Award A Restricted Stock Units 256,000 0.00 256,000 D
2025-10-01 Neal James R Director A-Award A Restricted Stock Units 100,000 0.00 100,000 D
2025-10-01 Lin Patrick Officer A-Award A Stock Options (Right to Buy) 204,000 0.20 40.4K 204,000 D
2025-10-01 Guy Wendy Officer A-Award A Restricted Stock Units 50,000 0.00 50,000 D
2025-10-01 Bigora Sian Officer A-Award A Stock Options (Right to Buy) 288,000 0.20 57.0K 288,000 D
2025-10-01 Baluch Khoso Director A-Award A Restricted Stock Units 100,000 0.00 100,000 D
2025-07-24 Young David Director / Officer A-Award A Restricted Stock Units 1,813,133 0.00 1,821,016 D
2025-07-24 Yorke Justin W Director A-Award A Restricted Stock 175,299 0.00 206,505 D
2025-07-24 SKIBSTED RUSSELL Officer A-Award A Restricted Stock Units 1,775,044 0.00 1,803,044 D
2025-07-24 Pannu Geraldine Director A-Award A Restricted Stock 175,299 0.00 206,505 D
2025-07-24 Ng George K Director / Officer A-Award A Restricted Stock Units 1,822,471 0.00 1,922,471 D
2025-07-24 Neal James R Director A-Award A Restricted Stock 175,299 0.00 206,505 D
2025-07-24 Lin Patrick Officer A-Award A Restricted Stock Units 1,401,650 0.00 1,412,082 D
2025-07-24 Guy Wendy Officer A-Award A Restricted Stock Units 1,366,046 0.00 1,376,478 D
2025-07-24 Bigora Sian Officer A-Award A Restricted Stock Units 1,659,185 0.00 1,672,087 D
2025-07-24 Baluch Khoso Director A-Award A Restricted Stock 175,299 0.00 206,505 D
2025-04-01 Young David Director / Officer F-InKind D Common Stock 5,345 0.41 2.2K 217,332 D
2025-04-01 Lin Patrick Officer F-InKind D Common Stock 4,814 0.41 2.0K 38,727 D
2025-04-01 Guy Wendy Officer M-Exempt A Common Stock 14,482 0.00 26,339 D
2025-04-01 Bigora Sian Officer F-InKind D Common Stock 3,311 0.41 1.4K 33,626 D
2025-01-29 Young David Director / Officer A-Award A Warrants 124,500 0.65 80.9K 124,500 D
2025-01-29 Yorke Justin W Director A-Award A Warrants 12,400 0.65 8.1K 12,400 I
2025-01-29 Ng George K Director / Officer A-Award A Warrants 87,200 0.65 56.7K 87,200 I
2025-01-29 Lin Patrick Officer A-Award A Warrants 43,500 0.65 28.3K 43,500 I
2025-01-27 Young David Director / Officer P-Purchase A Common Stock 124,500 0.80 99.3K 205,405 D
2025-01-27 Yorke Justin W Director P-Purchase A Common Stock 12,400 0.80 9.9K 12,400 I
2025-01-27 Ng George K Director / Officer P-Purchase A Common Stock 87,200 0.80 69.5K 87,200 I
2025-01-27 Lin Patrick Officer P-Purchase A Common Stock 43,500 0.80 34.7K 43,500 I
2024-09-03 Yorke Justin W Director A-Award A Restricted Stock 31,206 0.00 31,206
2024-09-03 Pannu Geraldine Director A-Award A Restricted Stock 31,206 0.00 31,206
2024-09-03 Neal James R Director A-Award A Restricted Stock 31,206 0.00 31,206
2024-09-03 Baluch Khoso Director A-Award A Restricted Stock 31,206 0.00 31,206
2024-07-16 SKIBSTED RUSSELL 0 0.00 0
2024-07-10 Young David Director / Officer M-Exempt A Common Stock 644 0.00 81,187
2024-07-10 Stanker James H Officer M-Exempt A Common Stock 644 0.00 6,764
2024-07-10 Lin Patrick Officer M-Exempt A Common Stock 644 0.00 29,330
2024-07-10 Guy Wendy Officer M-Exempt A Common Stock 644 0.00 12,077
2024-07-10 Bigora Sian Officer F-InKind D Common Stock 225 1.71 384.75 21,878
2024-06-28 Young David Director / Officer A-Award A Restricted Stock Units 404 0.00 25,155
2024-06-28 Stanker James H Officer A-Award A Restricted Stock Units 385 0.00 29,547
2024-06-28 Lin Patrick Officer A-Award A Restricted Stock Units 2,035 0.00 24,236
2024-06-28 Guy Wendy Officer A-Award A Restricted Stock Units 339 0.00 24,575
2024-06-28 Bigora Sian Officer A-Award A Restricted Stock Units 3,233 0.00 24,728
2024-04-05 Young David Director / Officer F-InKind D Common Stock 518 2.79 1.4K 80,543
2024-04-05 Stanker James H Officer M-Exempt A Common Stock 1,675 0.00 6,638
2024-04-05 Lin Patrick Officer M-Exempt A Common Stock 1,675 0.00 29,225
2024-04-05 Guy Wendy Officer M-Exempt A Common Stock 1,675 0.00 11,801
2024-04-05 Bigora Sian Officer F-InKind D Common Stock 368 2.79 1.0K 21,459
2024-02-07 Young David Director / Officer P-Purchase A Common Stock 21,000 2.45 51.5K 79,387
2024-02-06 Young David Director / Officer P-Purchase A Common Stock 20,000 2.53 50.5K 58,387
2024-02-01 Lin Patrick Officer P-Purchase A Common Stock 1,500 2.40 3.6K 27,478
2024-01-31 Lin Patrick Officer P-Purchase A Common Stock 2,500 2.37 5.9K 25,978
2024-01-30 Yorke Justin W Director P-Purchase A Common Stock 8,000 2.69 21.5K 31,232
2024-01-30 Ng George K Director / Officer P-Purchase A Common Stock 10,000 2.70 27.0K 20,000
2024-01-01 Young David Director / Officer M-Exempt D Restricted Stock Units 1,675 0.00 19,333
2024-01-01 Stanker James H Officer F-InKind D Common Stock 518 2.79 1.4K 6,120
2024-01-01 Lin Patrick Officer M-Exempt D Restricted Stock Units 1,675 0.00 20,132
2024-01-01 Guy Wendy Officer F-InKind D Common Stock 368 2.79 1.0K 11,433
2024-01-01 Bigora Sian Officer M-Exempt A Common Stock 1,675 0.00 21,826
2023-11-21 Yorke Justin W Director J-Other D Common Stock 55,267 0.00 464,623
2023-10-12 Young David Director / Officer / 10% Owner A-Award A Common Stock 155,277 0.29 45.0K 767,701
2023-10-12 Yorke Justin W Director A-Award A Common Stock 6,000 0.30 1.8K 75,729
2023-10-12 Stanker James H Officer A-Award A Common Stock 15,000 0.33 5.0K 99,250
2023-10-12 Ng George K Director / Officer A-Award A Common Stock 100,000 0.25 25.0K 200,000
2023-10-12 Lin Patrick Officer A-Award A Common Stock 5,000 0.32 1.6K 469,535
2023-10-12 Guy Wendy Officer A-Award A Common Stock 14,771 0.34 5.0K 202,517
2023-10-10 Young David Director / Officer / 10% Owner A-Award A Common Stock 142,000 0.24 34.1K 612,424
2023-10-10 Yorke Justin W Director A-Award A Common Stock 12,000 0.21 2.5K 69,729
2023-10-10 Stanker James H Officer A-Award A Common Stock 22,500 0.24 5.4K 84,250
2023-10-10 Pannu Geraldine Director A-Award A Common Stock 4,500 0.21 945.00 57,613
2023-10-10 Ng George K Director / Officer A-Award A Common Stock 100,000 0.25 25.0K 100,000
2023-10-10 Lin Patrick Officer A-Award A Common Stock 13,700 0.21 2.9K 464,535
2023-08-08 Ng George K Officer A-Award A Restricted Stock Units 400,000 0.00 400,000
2023-06-27 Yorke Justin W Director M-Exempt A Common Stock 23,636 0.00 56,729
2023-06-27 THOMPSON VIRGIL Director A-Award A Restricted Stock 101,365 0.00 101,365
2023-06-27 Pannu Geraldine Director M-Exempt D Restricted Stock 23,636 0.00 0
2023-06-27 Neal James R Director M-Exempt D Restricted Stock 14,407 0.00 0
2023-06-27 Baluch Khoso Director M-Exempt D Restricted Stock 15,455 0.00 0
2023-06-12 Young David Director / Officer / 10% Owner P-Purchase A Common Stock 40,000 0.80 32.0K 470,424
2023-04-14 Young David Director / Officer / 10% Owner P-Purchase A Common Stock 20,000 0.55 11.0K 430,424
2023-04-13 Young David Director / Officer / 10% Owner P-Purchase A Common Stock 20,000 0.48 9.6K 410,424
2023-04-12 Young David Director / Officer / 10% Owner P-Purchase A Common Stock 20,000 0.45 9.0K 390,424
2023-04-11 Young David Director / Officer / 10% Owner P-Purchase A Common Stock 20,000 0.52 10.4K 370,424
2023-02-09 Young David Director / Officer / 10% Owner A-Award A Common Stock 18,750 0.80 15.0K 350,424
2023-02-09 Stanker James H Officer A-Award A Common Stock 12,500 0.80 10.0K 61,750
2023-02-09 Lin Patrick Officer A-Award A Common Stock 12,500 0.80 10.0K 450,835
2023-02-09 Floyd Robert Michael Officer A-Award A Common Stock 10,000 0.80 8.0K 82,267
2023-02-09 Baluch Khoso Director A-Award A Common Stock 12,500 0.80 10.0K 12,500
2023-01-01 Young David Officer A-Award A Restricted Stock Units 24,030 0.00 424,373
2023-01-01 Yorke Justin W Director A-Award A Restricted Stock 30,000 0.00 30,000
2023-01-01 THOMPSON VIRGIL Director A-Award A Restricted Stock 30,000 0.00 30,000
2023-01-01 Stanker James H Officer A-Award D Restricted Stock Units 96,150 0.00 518,431
2023-01-01 Pannu Geraldine Director A-Award A Restricted Stock 30,000 0.00 30,000
2023-01-01 Lin Patrick Officer A-Award A Restricted Stock Units 40,690 0.00 440,328
2023-01-01 Guy Wendy Officer A-Award A Restricted Stock Units 40,690 0.00 440,328
2023-01-01 Floyd Robert Michael Officer A-Award A Restricted Stock Units 40,690 0.00 440,328
2023-01-01 Bigora Sian Officer A-Award A Restricted Stock Units 48,490 0.00 480,475
2022-12-31 Young David Officer A-Award A Restricted Stock Units 25,350 0.00 400,343
2022-12-31 Yorke Justin W Director A-Award A Common Stock 18,208 0.00 33,093
2022-12-31 THOMPSON VIRGIL Director M-Exempt A Common Stock 18,208 0.00 100,213
2022-12-31 Stanker James H Officer A-Award D Restricted Stock Units 12,951 0.00 352,614
2022-12-31 Pannu Geraldine Director M-Exempt A Common Stock 18,208 0.00 29,477
2022-12-31 Lin Patrick Officer A-Award A Restricted Stock Units 10,851 0.00 344,531
2022-12-31 Guy Wendy Officer A-Award A Restricted Stock Units 10,851 0.00 344,531
2022-12-31 Floyd Robert Michael Officer A-Award A Restricted Stock Units 10,851 0.00 344,531
2022-12-31 Bigora Sian Officer A-Award A Restricted Stock Units 13,851 0.00 356,073
2022-10-06 Floyd Robert Michael Officer M-Exempt A Common Stock 12,500 0.00 76,430
2022-09-30 Young David Officer A-Award A Restricted Stock Units 25,350 0.00 374,993
2022-09-30 Stanker James H Officer A-Award D Restricted Stock Units 23,947 0.00 326,713
2022-09-30 Lin Patrick Officer A-Award A Restricted Stock Units 10,850 0.00 333,680
2022-09-30 Guy Wendy Officer A-Award A Restricted Stock Units 10,850 0.00 333,680
2022-09-30 Floyd Robert Michael Officer A-Award A Restricted Stock Units 10,850 0.00 333,680
2022-09-30 Bigora Sian Officer A-Award A Restricted Stock Units 13,850 0.00 342,227
2022-08-16 Young David Officer G-Gift D Common Stock 9,250 0.00 377,784
2022-08-16 Floyd Robert Michael Officer G-Gift D Common Stock 7,000 0.00 63,930
2022-08-05 Young David Officer F-InKind D Common Stock 2,531 3.17 8.0K 387,034
2022-08-05 Yorke Justin W Director A-Award A Common Stock 4,393 0.00 13,716
2022-08-05 THOMPSON VIRGIL Director M-Exempt A Common Stock 1,169 0.00 16,693
2022-08-05 Stanker James H Officer F-InKind D Common Stock 2,462 3.17 7.8K 49,250
2022-08-05 Pannu Geraldine Director M-Exempt A Common Stock 1,169 0.00 11,269
2022-08-05 Lin Patrick Officer F-InKind D Common Stock 2,656 3.17 8.4K 438,335
2022-08-05 Guy Wendy Officer F-InKind D Common Stock 1,782 3.17 5.6K 187,746
2022-08-05 Bigora Sian Officer M-Exempt A Common Stock 7,601 0.00 403,019
2022-07-19 Neal James R Director A-Award A Restricted Stock 17,797 0.00 17,797
2022-07-12 Baluch Khoso Director A-Award A Restricted Stock 19,091 0.00 19,091
2022-07-11 Baluch Khoso Director 0 0.00 0
2022-06-30 Young David Officer A-Award A Restricted Stock Units 46,877 0.00 349,643
2022-06-30 Stanker James H Officer A-Award D Restricted Stock Units 23,947 0.00 326,713
2022-06-30 Lin Patrick Officer A-Award A Restricted Stock Units 20,064 0.00 322,830
2022-06-30 Guy Wendy Officer A-Award A Restricted Stock Units 20,064 0.00 322,830
2022-06-30 Floyd Robert Michael Officer A-Award A Restricted Stock Units 20,064 0.00 322,830
2022-06-30 Bigora Sian Officer A-Award A Restricted Stock Units 25,611 0.00 328,377
2022-05-17 Lin Patrick Officer P-Purchase A Common Stock 2,000 1.59 3.2K 433,390
2022-04-06 Lin Patrick Officer P-Purchase A Common Stock 1,200 3.13 3.8K 430,590
2022-04-01 Young David Officer A-Award A Restricted Stock Units 247,841 0.00 302,766
2022-04-01 Stanker James H Officer A-Award D Restricted Stock Units 247,841 0.00 302,766
2022-04-01 Lin Patrick Officer A-Award A Restricted Stock Units 247,841 0.00 302,766
2022-04-01 Guy Wendy Officer A-Award A Restricted Stock Units 247,841 0.00 302,766
2022-04-01 Floyd Robert Michael Officer A-Award A Restricted Stock Units 247,841 0.00 302,766
2022-04-01 Bigora Sian Officer A-Award A Restricted Stock Units 247,841 0.00 302,766
2022-03-31 Young David Director / Officer / 10% Owner A-Award A Restricted Stock Units 10,715 0.00 37,781
2022-03-31 Yorke Justin W Director A-Award A Common Stock 4,393 0.00 13,716
2022-03-31 THOMPSON VIRGIL Director A-Award A Common Stock 4,393 0.00 16,693
2022-03-31 Stanker James H Officer A-Award D Restricted Stock Units 10,715 0.00 37,781
2022-03-31 Pannu Geraldine Director A-Award A Common Stock 4,393 0.00 10,100
2022-03-31 Lin Patrick Officer A-Award A Restricted Stock Units 10,715 0.00 37,781
2022-03-31 Islam Khalid Director A-Award A Common Stock 4,392 0.00 72,486
2022-03-31 Guy Wendy Officer A-Award A Restricted Stock Units 10,715 0.00 37,781
2022-03-31 Floyd Robert Michael Officer G-Gift D Common Stock 7,000 0.00 70,930
2022-03-31 Bigora Sian Officer A-Award A Restricted Stock Units 10,715 0.00 37,781
2022-03-15 Yorke Justin W Director A-Award A Restricted Stock 18,208 0.00 19,377
2022-03-15 THOMPSON VIRGIL Director A-Award A Restricted Stock 18,208 0.00 19,377
2022-03-15 Pannu Geraldine Director A-Award A Restricted Stock 18,208 0.00 19,377
2022-03-15 Islam Khalid Director A-Award A Restricted Stock 18,208 0.00 18,208
2022-01-27 Yorke Justin W Director S-Sale D Common Stock 1,854 3.30 6.1K 532,563
2022-01-01 Yorke Justin W Director A-Award A Restricted Stock 18,208 0.00 19,377
2022-01-01 THOMPSON VIRGIL Director A-Award A Restricted Stock 18,208 0.00 19,377
2022-01-01 Islam Khalid Director A-Award A Restricted Stock 18,208 0.00 18,208
2021-12-31 Young David Director / Officer / 10% Owner A-Award A Restricted Stock Units 6,722 0.00 6,722
2021-12-31 Stanker James H Officer A-Award D Restricted Stock Units 6,722 0.00 22,780
2021-12-31 Lin Patrick Officer A-Award A Restricted Stock Units 6,722 0.00 22,780
2021-12-31 Guy Wendy Officer A-Award D Restricted Stock Units 6,722 0.00 22,780
2021-12-31 Floyd Robert Michael Officer A-Award A Restricted Stock Units 6,722 0.00 22,780
2021-12-31 Bigora Sian Officer A-Award A Restricted Stock Units 6,722 0.00 22,780
2021-12-14 Lin Patrick Officer P-Purchase A Common Stock 3,000 4.00 12.0K 429,390
2021-12-06 Yorke Justin W Director S-Sale D Common Stock 4,200 4.71 19.8K 534,417

Executive team

Top executives
Shares Outstanding
2.27M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2024 George Ng Chief Executive Officer 400.0K 100.0K 21.0K 521.0K 0.00%
2 2024 Sian Bigora Chief Development and Regulatory Officer 290.9K 14.5K 22.8K 328.3K 4.41%
3 2024 David Young President, Research and Development and former Chief Executive Officer 290.9K 14.5K 305.4K 4.74%
4 2023 George Ng Chief Executive Officer 159.1K 312.0K 471.1K 66.23%
5 2023 Sian Bigora Chief Development and Regulatory Officer 160.2K 136.8K 24.7K 321.7K 42.54%
6 2023 David Young President, Research and Development and former Chief Executive Officer 160.2K 26.4K 186.6K 14.16%
7 2022 David Young Chief Executive Officer 93.9K 1.07M 1.16M 91.93%
8 2022 Sian Bigora Chief Development Officer 93.9K 955.2K 26.4K 1.08M 88.81%
9 2022 Patrick Lin Chief Business and Strategy Officer 93.9K 925.6K 23.3K 1.04M 88.77%
10 2022 Michael Floyd Chief Operations Officer 93.9K 925.6K 22.9K 1.04M 88.80%
11 2022 James Stanker Chief Financial Officer 93.9K 946.3K 1.04M 90.98%
12 2022 Wendy Guy Chief Administrative Officer 93.9K 925.6K 313.00 1.02M 90.76%
13 2021 Michael Floyd Chief Operations Officer 87.5K 596.4K 22.3K 706.2K 84.45%
14 2021 Sian Bigora Chief Development Officer 87.5K 347.0K 25.6K 460.1K 75.42%
15 2021 Patrick Lin Chief Business and Strategy Officer 87.5K 347.0K 22.0K 456.5K 76.02%
16 2021 Wendy Guy Chief Administrative Officer 87.5K 347.0K 295.00 434.8K 79.81%
17 2021 David Young Chief Executive Officer 87.5K 347.0K 434.5K 79.86%
18 2021 James Stanker Chief Financial Officer 87.5K 347.0K 434.5K 79.86%
19 2020 Sian Bigora Chief Development Officer 75.8K 380.1K 24.6K 480.5K 79.09%
20 2020 Dr. Sian Bigora Chief Development Officer 75.8K 380.1K 24.6K 480.5K 79.09%
21 2020 Patrick Lin Chief Business and Strategy Officer 75.5K 380.1K 20.7K 476.2K 79.80%
22 2020 Wendy Guy Chief Administrative Officer 87.5K 380.1K 907.00 468.5K 81.13%
23 2020 James Stanker Chief Financial Officer 87.5K 380.1K 467.6K 81.29%
24 2020 David Young Chief Executive Officer 58.3K 380.1K 438.4K 86.69%
25 2020 Dr. David Young Chief Executive Officer 58.3K 380.1K 438.4K 86.69%
26 2020 Michael Floyd Chief Operations Officer 21.9K 50.0K 5.6K 77.5K 64.56%
27 2019 Wendy Guy Chief Administrative Officer 87.5K 163.2K 4.9K 250.7K 65.10%
28 2019 James Stanker Chief Financial Officer 87.5K 163.2K 250.7K 65.10%
29 2019 Patrick Lin Chief Business and Strategy Officer 52.5K 163.2K 19.6K 215.7K 75.66%
30 2019 Dr. Sian Bigora Chief Development Officer 52.5K 163.2K 26.9K 215.7K 75.66%
31 2019 Dr. David Young Chief Executive Officer 163.2K 163.2K 100.00%
32 2018 James Stanker Chief Financial Officer 29.2K 700.4K 729.6K 96.00%
33 2018 Wendy Guy Chief Administrative Officer 87.5K 87.5K 0.00%
34 2018 Sian Bigora Chief Development Officer 50.8K 50.8K 0.00%
35 2018 Patrick Lin Chief Business and Strategy Officer 44.5K 44.5K 0.00%
36 2017 Wendy Guy Chief Administrative Officer 87.5K 87.5K 0.00%
37 2017 Sian Bigora Chief Development Officer 52.5K 52.5K 0.00%
38 2017 Patrick Lin Chief Business and Strategy Officer 25.0K 25.0K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-08-25 DEFA14A
2025-08-13 DEF 14A
2025-07-31 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-19 4/A
2026-05-19 4/A
2026-05-19 4
2026-05-19 4
2026-05-19 4
2026-05-19 4
2026-05-19 4
2026-05-15 SC 13G/A
2026-05-07 10-Q
2026-05-01 4

Executive team

NameTitleCompensationGender
Russell L. Skibsted Chief Financial Officer 482.7K male
George K. Ng Chief Executive Officer & Director 473.9K male
Sian E. Bigora Co-Founder and Chief Development & Regulatory Officer 420.3K
David Young Co-Founder, President of Research and Development & Director 290.9K
Patrick Lin Co-Founder, Chief Business & Strategy Officer 117.2K male
Wendy J. Guy Co-Founder, Chief Administrative Officer & Corporate Secretary 94.2K female
Steven Cha Senior Vice President of Clinical Research
ESG Rating
B
BIOTECHNOLOGY
2025
E (Environmental)
44.5 / 56.3
Company / Sector avg.
S (Social)
74.7 / 62.4
Company / Sector avg.
G (Governance)
68.8 / 60.9
Company / Sector avg.
ESG Total
62.7 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits